Efficient and reproducible generation of high-expressing, stable human cell lines without need for antibiotic selection
Open Access
- 1 January 2008
- journal article
- Published by Springer Nature in BMC Biotechnology
- Vol. 8 (1) , 13
- https://doi.org/10.1186/1472-6750-8-13
Abstract
Human cell lines are the most innovative choice of host cell for production of biopharmaceuticals since they allow for authentic posttranslational modification of therapeutic proteins. We present a new method for generating high and stable protein expressing cell lines based on human amniocytes without the requirement of antibiotic selection.Keywords
This publication has 34 references indexed in Scilit:
- Comparative properties of human α‐1‐proteinase inhibitor glycosylation variantsFEBS Letters, 1990
- The human cytomegalovirus immediate early enhancer-promoter is responsive to activation by the adenovirus-5 13S E1A geneArchiv für die gesamte Virusforschung, 1990
- Transcription activation by the adenovirus E1a proteinNature, 1989
- TRANSFORMATION OF HUMAN-EMBRYO RETINOBLASTS WITH SIMIAN VIRUS-40, ADENOVIRUS AND RAS ONCOGENES1986
- Analyses of mutation in pSV2gpt-transformed CHO cellsMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1986
- Unglycosylated rat α1-proteinase inhibitor has a six-fold shorter plasma half-life than the mature glycoproteinBiochemical and Biophysical Research Communications, 1985
- Construction of human cell lines which contain and express the adenovirus DNA binding protein gene by cotransformation with the HSV-1 tk geneVirus Research, 1984
- Interaction of mature, unglycosylated and cell‐free synthesized rat α1‐proteinase inhibitor with elastaseEuropean Journal of Biochemistry, 1983
- DNA-mediated gene transfer in Chinese hamster ovary cells: Clonal variation in transfer efficiencyMolecular Genetics and Genomics, 1982
- Isolation of Chinese hamster cell mutants deficient in dihydrofolate reductase activity.Proceedings of the National Academy of Sciences, 1980